Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19

We presented the clinical course and immune responses of a well-controlled HIV-positive patient with COVID-19. The clinical presentation and antibody production to SARS-CoV-2 were similar to other COVID-19 patients without HIV infection. Neutralizing antibody reached a plateau from 26th to 47th day...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wang-Da, Hung, Chien-Ching, Wang, Jann-Tay, Tsai, Ming-Jui, Kuo, Po-Hsien, Chao, Tai-Ling, Hsieh, Szu-Min, Sheng, Wang-Huei, Chen, Yee-Chun, Chang, Sui-Yuan, Chang, Shan-Chwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Formosan Medical Association. Published by Elsevier Taiwan LLC. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059939/
https://www.ncbi.nlm.nih.gov/pubmed/33933336
http://dx.doi.org/10.1016/j.jfma.2021.04.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059939/
https://www.ncbi.nlm.nih.gov/pubmed/33933336
http://dx.doi.org/10.1016/j.jfma.2021.04.010

Ejemplares similares